论文部分内容阅读
评价还原型谷胱甘肽滴眼液在治疗角膜上皮病变中的疗效,探讨还原型谷胱甘肽对角膜上皮病变的疗效价值。将60例69眼角膜上皮病例随机分为谷胱甘肽滴眼液治疗组(30例38眼)即Ⅰ组及人工泪液卡波姆滴眼液组(30例31眼)Ⅱ组,观察两组治疗效果。经2周的治疗和随访,Ⅰ组治愈27眼,有效7眼,总有效率是89.5%,Ⅱ组治愈11眼,有效4眼,总有效率48.4%。两组的治愈率与好转率差异有统计学意义(P<0.05)。谷胱甘肽滴眼液可作为一种角膜营养剂,促进角膜上皮的损伤修复。
To evaluate the efficacy of reduced glutathione eye drops in the treatment of corneal epithelial lesions, and to evaluate the therapeutic value of reduced glutathione on corneal epithelial lesions. 60 cases of 69 cases of corneal epithelial cases were randomly divided into glutathione eye drops treatment group (30 cases, 38 eyes) group Ⅰ and artificial tear carbomer eye drops group (30 eyes 31 cases) Ⅱ, observed two Group treatment effect. After 2 weeks of treatment and follow-up, 27 eyes were cured in group Ⅰ, 7 eyes were effective, the total effective rate was 89.5%, 11 eyes were cured in group Ⅱ, 4 eyes were effective, and the total effective rate was 48.4%. The two groups of cure rate and improvement rate difference was statistically significant (P <0.05). Glutathione eye drops can be used as a corneal nutrient to promote corneal epithelial injury repair.